At the time of writing, Resmed Inc. [RMD] stock is trading at $237.40, down -1.08%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RMD shares have lost -0.39% over the last week, with a monthly amount drifted -3.94%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Resmed Inc. [NYSE: RMD] stock has seen the most recent analyst activity on September 24, 2024, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $280. Previously, Wolfe Research downgraded its rating to Underperform on September 18, 2024, and kept the price target unchanged to $180. On September 04, 2024, downgrade downgraded it’s rating to Hold. Oppenheimer downgraded its rating to a Perform. Citigroup downgraded its rating to a Neutral. In a note dated October 27, 2023, Morgan Stanley upgraded an Overweight rating on this stock and revised its target price from $180 to $169.
For the past year, the stock price of Resmed Inc. fluctuated between $132.24 and $255.18. Currently, Wall Street analysts expect the stock to reach $219.13 within the next 12 months. Resmed Inc. [NYSE: RMD] shares were valued at $237.40 at the most recent close of the market. An investor can expect a potential drop of -7.7% based on the average RMD price forecast.
Analyzing the RMD fundamentals
According to Resmed Inc. [NYSE:RMD], the company’s sales were 4.69B for trailing twelve months, which represents an 9.01% jump. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.28%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.15, Equity is 0.22 and Total Capital is 0.22. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 234.91 points at the first support level, and at 232.43 for the second support level. However, for the 1st resistance point, the stock is sitting at 240.05, and for the 2nd resistance point, it is at 242.71.
Ratios To Look Out For
It is important to note that Resmed Inc. [NYSE:RMD] has a current ratio of 2.59. As well, the Quick Ratio is 1.69, while the Cash Ratio is 0.26. Considering the valuation of this stock, the price to sales ratio is 7.44, the price to book ratio is 7.17 and price to earnings (TTM) ratio is 34.30.
Transactions by insiders
Recent insider trading involved Ghoshal Kaushik, Chief Commercial Officer, SaaS, that happened on Oct 11 ’24 when 4260.0 shares were sold. Officer, Ghoshal Kaushik completed a deal on Oct 11 ’24 to buy 4260.0 shares. Meanwhile, Chief Financial Officer Sandercock Brett sold 1000.0 shares on Oct 08 ’24.
